Cargando…

Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670

Detalles Bibliográficos
Autores principales: Kim, Ji Woong, Cho, Yea Bin, Lee, Sukmook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153583/
https://www.ncbi.nlm.nih.gov/pubmed/34069315
http://dx.doi.org/10.3390/cells10051198
_version_ 1783698831507980288
author Kim, Ji Woong
Cho, Yea Bin
Lee, Sukmook
author_facet Kim, Ji Woong
Cho, Yea Bin
Lee, Sukmook
author_sort Kim, Ji Woong
collection PubMed
description
format Online
Article
Text
id pubmed-8153583
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81535832021-05-27 Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670 Kim, Ji Woong Cho, Yea Bin Lee, Sukmook Cells Correction MDPI 2021-05-14 /pmc/articles/PMC8153583/ /pubmed/34069315 http://dx.doi.org/10.3390/cells10051198 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Kim, Ji Woong
Cho, Yea Bin
Lee, Sukmook
Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
title Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
title_full Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
title_fullStr Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
title_full_unstemmed Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
title_short Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
title_sort correction: kim et al. cell surface grp94 as a novel emerging therapeutic target for monoclonal antibody cancer therapy. cells 2021, 10, 670
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153583/
https://www.ncbi.nlm.nih.gov/pubmed/34069315
http://dx.doi.org/10.3390/cells10051198
work_keys_str_mv AT kimjiwoong correctionkimetalcellsurfacegrp94asanovelemergingtherapeutictargetformonoclonalantibodycancertherapycells202110670
AT choyeabin correctionkimetalcellsurfacegrp94asanovelemergingtherapeutictargetformonoclonalantibodycancertherapycells202110670
AT leesukmook correctionkimetalcellsurfacegrp94asanovelemergingtherapeutictargetformonoclonalantibodycancertherapycells202110670